- Home
- NFE vs RNAC Comparison
NFE vs RNAC Comparison
Compare NFE & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NFE | RNAC |
|---|---|---|
| Founded | 2014 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil/Gas Transmission | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 324.4M | 283.2M |
| IPO Year | 2018 | 2016 |
Fundamental Metrics
Financial Performance| Metric | NFE | RNAC |
|---|---|---|
| Price | $0.35 | $9.42 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | $5.50 | ★ $34.00 |
| AVG Volume (30 Days) | ★ 4.8M | 439.1K |
| Earning Date | 04-13-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,504,037,000.00 | $2,797,000.00 |
| Revenue This Year | $110.34 | N/A |
| Revenue Next Year | $3.54 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.37 | $5.60 |
| 52 Week High | $4.96 | $14.56 |
Technical Indicators
Market Signals| Indicator | NFE | RNAC |
|---|---|---|
| Relative Strength Index (RSI) | 25.64 | 58.59 |
| Support Level | N/A | $9.13 |
| Resistance Level | $0.54 | $9.82 |
| Average True Range (ATR) | 0.04 | 1.19 |
| MACD | -0.01 | 0.13 |
| Stochastic Oscillator | 10.78 | 69.50 |
Price Performance
Historical ComparisonAbout NFE New Fortress Energy Inc.
New Fortress Energy Inc is an integrated gas-to-power company. Its business model spans the entire production and delivery chain from natural gas procurement and liquefaction to logistics, shipping, terminals, and conversion or development of a natural gas-fired generation. It has invested in floating, liquefied natural gas vessels to lower the cost of acquiring gas while securing a long-term supply for its terminals. Its segments include Terminals & Infrastructure, and Ships. It generates the majority of its revenue from the Terminals & Infrastructure segment.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.